Ìð¹ÏÊÓƵ

Matthew C. Weed
No Rating Available
(Learn About Our Rating System)

Matthew C. Weed, MD

Languages spoken: English, Spanish

Clinical Locations

Primary Children's Hospital

Pediatric Ophthalmology
Salt Lake City
801-581-2352

Primary Children's Hospital - Lehi

Pediatric Ophthalmology
Lehi

  • Matthew C. Weed, MD, is a pediatric ophthalmologist providing medical and surgical care for Ìð¹ÏÊÓƵren with eye disease and adults with strabismus (eye misalignment).

    Dr. Weed takes care of Ìð¹ÏÊÓƵren with ‘lazy eye’ (amblyopia), strabismus, nasolacrimal duct obstruction/tear duct blockage, cataracts, retinopathy of prematurity, the need for glasses, and many other conditions. He also enjoys providing care for adults with strabismus and helping his patients by creating customized treatment plans designed for their needs.

    Dr. Weed provides the region’s highest level of specialized training in pediatric inherited retinal diseases, including conditions like retinitis pigmentosa, Stargardt disease, Best disease, Usher syndrome, cone dystrophy, and Leber congenital amaurosis.

    He earned his medical degree from the Ìð¹ÏÊÓƵ of California San Diego School of Medicine in 2010 and completed his ophthalmology residency at the Ìð¹ÏÊÓƵ of Iowa Department of Ophthalmology. Dr. Weed then completed two fellowships, also at the Ìð¹ÏÊÓƵ of Iowa, one in ophthalmic genetics and a second in pediatric ophthalmology and strabismus.

    Since joining the Moran Eye Center in 2025, Dr. Weed heads a monthly pediatric inherited retinal disease clinic located at Primary Children’s Hospital in Salt Lake City. The clinic streamlines patient care by offering clinical evaluation, genetic testing, and a genetic counselor all in the same location.

    A member of the American Academy of Ophthalmology, the American Association for Pediatric Ophthalmology and Strabismus, and the Pediatric Eye Disease Investigator Group, Dr. Weed has participated in clinical studies evaluating amblyopia and myopia in Ìð¹ÏÊÓƵren and published in peer-reviewed journals. He is certified by the American Board of Ophthalmology. In 2015 he received the P.J. Leinfelder Award for Research Excellence from the Ìð¹ÏÊÓƵ of Iowa Department of Ophthalmology.

    A Salt Lake City native and graduate of Brigham Young Ìð¹ÏÊÓƵ, Dr. Weed is fluent in Spanish and enjoys bodysurfing, backpacking, family time, and making his own slow-smoked barbecue.

    Specialties

    Board Certification

    American Board of Ophthalmology

  • Matthew C. Weed, MD, is a pediatric ophthalmologist providing medical and surgical care for Ìð¹ÏÊÓƵren with eye disease and adults with strabismus (eye misalignment).

    Dr. Weed takes care of Ìð¹ÏÊÓƵren with ‘lazy eye’ (amblyopia), strabismus, nasolacrimal duct obstruction/tear duct blockage, cataracts, retinopathy of prematurity, the need for glasses, and many other conditions. He also enjoys providing care for adults with strabismus and helping his patients by creating customized treatment plans designed for their needs.

    Dr. Weed provides the region’s highest level of specialized training in pediatric inherited retinal diseases, including conditions like retinitis pigmentosa, Stargardt disease, Best disease, Usher syndrome, cone dystrophy, and Leber congenital amaurosis.

    He earned his medical degree from the Ìð¹ÏÊÓƵ of California San Diego School of Medicine in 2010 and completed his ophthalmology residency at the Ìð¹ÏÊÓƵ of Iowa Department of Ophthalmology. Dr. Weed then completed two fellowships, also at the Ìð¹ÏÊÓƵ of Iowa, one in ophthalmic genetics and a second in pediatric ophthalmology and strabismus.

    Since joining the Moran Eye Center in 2025, Dr. Weed heads a monthly pediatric inherited retinal disease clinic located at Primary Children’s Hospital in Salt Lake City. The clinic streamlines patient care by offering clinical evaluation, genetic testing, and a genetic counselor all in the same location.

    A member of the American Academy of Ophthalmology, the American Association for Pediatric Ophthalmology and Strabismus, and the Pediatric Eye Disease Investigator Group, Dr. Weed has participated in clinical studies evaluating amblyopia and myopia in Ìð¹ÏÊÓƵren and published in peer-reviewed journals. He is certified by the American Board of Ophthalmology. In 2015 he received the P.J. Leinfelder Award for Research Excellence from the Ìð¹ÏÊÓƵ of Iowa Department of Ophthalmology.

    A Salt Lake City native and graduate of Brigham Young Ìð¹ÏÊÓƵ, Dr. Weed is fluent in Spanish and enjoys bodysurfing, backpacking, family time, and making his own slow-smoked barbecue.

    Board Certification and Academic Information

    Academic Departments Ophthalmology & Visual Sciences -Associate Professor (Clinical)
    Board Certification
    American Board of Ophthalmology

    Education history

    Fellowship Pediatric Ophthalmology & Strabismus - Ìð¹ÏÊÓƵ of Iowa Roy J. and Lucille A. Carver College of Medicine Fellow
    Fellowship Ophthalmic Genetics - Ìð¹ÏÊÓƵ of Iowa Roy J. and Lucille A. Carver College of Medicine Fellow
    Residency Ophthalmology - Ìð¹ÏÊÓƵ of Iowa Roy J. and Lucille A. Carver College of Medicine Resident
    Internship Providence Sacred Heart Medical Center Transitional Internship
    Professional Medical Medicine - Ìð¹ÏÊÓƵ of California, San Diego School of Medicine M.D.
    Undergraduate Major: Microbiology; Minor: Spanish - Brigham Young Ìð¹ÏÊÓƵ B.S.

    Selected Publications

    Journal Article

    1. Cho DY, Evans KN, Weed MC, Lee A, Susarla SM (2020). Bilateral Squamosal Suture Craniosynostosis Presenting with Abducens Nerve Palsy and Severe Papilledema. World Neurosurg, 138, 344-348. ()

    Review

    1. Rashad R, Weed MC, Quinn N, Chen VM (2019). Extended Wear Bandage Contact Lenses Decrease Pain and Preserve Vision in Patients with Epidermolysis Bullosa: Case Series and Review of Literature. [Review]. Ocul Immunol Inflamm, 28(3), 379-383. ()
    2. Weed MC, Almeida DR, Chin EK, Stone EM (2016). Distinguishing optic pathway glioma and retinitis pigmentosa with visual field testing. [Review]. Can J Ophthalmol, 51(3), e94-6. ()
    3. DeLuca AP, Whitmore SS, Barnes J, Sharma TP, Westfall TA, Scott CA, Weed MC, Wiley JS, Wiley LA, Johnston RM, Schnieders MJ, Lentz SR, Tucker BA, Mullins RF, Scheetz TE, Stone EM, Slusarski DC (2015). Hypomorphic mutations in TRNT1 cause retinitis pigmentosa with erythrocytic microcytosis. [Review]. Hum Mol Genet, 25(1), 44-56. ()
    4. DeLuca AP, Weed MC, Haas CM, Halder JA, Stone EM (2015). Apparent Usher Syndrome Caused by the Combination of BBS1-Associated Retinitis Pigmentosa and SLC26A4-Associated Deafness. [Review]. JAMA Ophthalmol, 133(8), 967-8. ()
    5. Airmet KW, Hinckley JD, Tree LT, Moss M, Blumell S, Ulicny K, Gustafson AK, Weed M, Theodosis R, Lehnardt M, Genho J, Stevens MR, Kooyman DL (2012). Construction of a llama bacterial artificial chromosome library with approximately 9-fold genome equivalent coverage. [Review]. J Biomed Biotechnol, 2012, 371414. ()
    6. Chen Y, Zeng J, Zhao C, Wang K, Trood E, Buehler J, Weed M, Kasuga D, Bernstein PS, Hughes G, Fu V, Chin J, Lee C, Crocker M, Bedell M, Salasar F, Yang Z, Goldbaum M, Ferreyra H, Freeman WR, Kozak I, Zhang K (2011). Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors. [Review]. Arch Ophthalmol, 129(3), 344-51. ()
    7. Ruckstuhl H, Kho J, Weed M, Wilkinson MW, Hargens AR (2009). Comparing two devices of suspended treadmill walking by varying body unloading and Froude number. [Review]. Gait Posture, 30(4), 446-51. ()